Dyne Therapeutics Stock Forward View - Price Action Indicator
| DYN Stock | USD 17.89 0.19 1.07% |
Dyne Stock outlook is based on your current time horizon.
As of today, the value of RSI of Dyne Therapeutics' share price is approaching 45 suggesting that the stock is in nutural position, most likellhy at or near its support level. The main point of RSI analysis is to track how fast people are buying or selling Dyne Therapeutics, making its price go up or down. Momentum 45
Impartial
Oversold | Overbought |
Using Dyne Therapeutics hype-based prediction, you can estimate the value of Dyne Therapeutics from the perspective of Dyne Therapeutics response to recently generated media hype and the effects of current headlines on its competitors.
Dyne Therapeutics after-hype prediction price | USD 17.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Dyne Therapeutics to cross-verify your projections. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.Dyne Therapeutics Additional Predictive Modules
Most predictive techniques to examine Dyne price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Dyne using various technical indicators. When you analyze Dyne charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Price Action Indicator | Price Action Indicator | Trend |
| (0.16) | 0.24 |
| Check Dyne Therapeutics Volatility | Backtest Dyne Therapeutics | Information Ratio |
Dyne Therapeutics Trading Date Momentum
| On January 30 2026 Dyne Therapeutics was traded for 17.89 at the closing time. Highest Dyne Therapeutics's price during the trading hours was 18.23 and the lowest price during the day was 17.27 . There was no trading activity during the period 0.0. Lack of trading volume on the 30th of January did not affect price variability. The overall trading delta to current price is 1.06% . |
Price Action Indicator (or PAIN) was developed by Michael B. Geraty and published in 'Futures' magazine in August 1997.
| Compare Dyne Therapeutics to competition |
Other Forecasting Options for Dyne Therapeutics
For every potential investor in Dyne, whether a beginner or expert, Dyne Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Dyne Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Dyne. Basic forecasting techniques help filter out the noise by identifying Dyne Therapeutics' price trends.Dyne Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Dyne Therapeutics stock to make a market-neutral strategy. Peer analysis of Dyne Therapeutics could also be used in its relative valuation, which is a method of valuing Dyne Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Dyne Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Dyne Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Dyne Therapeutics shares will generate the highest return on investment. By undertsting and applying Dyne Therapeutics stock market strength indicators, traders can identify Dyne Therapeutics entry and exit signals to maximize returns.
Dyne Therapeutics Risk Indicators
The analysis of Dyne Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Dyne Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting dyne stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 3.32 | |||
| Standard Deviation | 4.7 | |||
| Variance | 22.1 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Dyne Therapeutics
The number of cover stories for Dyne Therapeutics depends on current market conditions and Dyne Therapeutics' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Dyne Therapeutics is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Dyne Therapeutics' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Dyne Therapeutics Short Properties
Dyne Therapeutics' future price predictability will typically decrease when Dyne Therapeutics' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Dyne Therapeutics often depends not only on the future outlook of the potential Dyne Therapeutics' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Dyne Therapeutics' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 94.1 M | |
| Cash And Short Term Investments | 642.3 M |
Check out Historical Fundamental Analysis of Dyne Therapeutics to cross-verify your projections. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne Therapeutics guide.You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Will Stock sector continue expanding? Could Dyne diversify its offerings? Factors like these will boost the valuation of Dyne Therapeutics. Projected growth potential of Dyne fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Dyne Therapeutics data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Dyne Therapeutics is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Dyne Therapeutics' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Dyne Therapeutics' market value can be influenced by many factors that don't directly affect Dyne Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
It's important to distinguish between Dyne Therapeutics' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Dyne Therapeutics should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Meanwhile, Dyne Therapeutics' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.